Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
  1. 4 Open-market buy Director bought 21,645 shares at $4.67 ($101,041)
  2. 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 2,298 shares at $4.57 ($10,502)
  3. 4 Open-market buy CHIEF PEOPLE OFFICER bought 2,626 shares at $4.15 ($10,906)
  4. 4 Open-market buy Director bought 20,000 shares at $4.35 ($86,904)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 7,500 shares at $6.67 ($50,025)
  8. 4 Open-market buy Chief Accounting Officer bought 300 shares at $6.39 ($1,917)
  9. 4 Open-market buy CHIEF PEOPLE OFFICER bought 800 shares at $6.38 ($5,103)
  10. 4 Open-market buy CHIEF LEGAL OFFICER, SECRETARY bought 1,020 shares at $6.83 ($6,966)
  11. 4 Open-market buy Director bought 7,500 shares at $7.03 ($52,730)
  12. 4 Open-market buy Director bought 5,000 shares at $7.18 ($35,900)
  13. 4 Grant or award CHIEF PEOPLE OFFICER acquired 11,815 shares (grant or award)
  14. 4 Grant or award Chief Accounting Officer acquired 14,497 shares (grant or award)
  15. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 14,880 shares (grant or award)
  16. 4 Open-market buy Director bought 5,500 shares at an average $3.61 ($19,863)
  17. 4 Open-market buy CHIEF PEOPLE OFFICER bought 700 shares at $3.57 ($2,499)
  18. 4 Open-market buy PRESIDENT AND CEO bought 10,000 shares at an average $3.49 ($34,879)
  19. 4 Open-market buy Director bought 9,500 shares at $3.66 ($34,788)
  20. 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 13,422 shares at an average $2.58 ($34,616)

Page 2 of 9 · 165 filings